Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Temporary Androgen Deprivation Therapy in High Risk Prostate Cancer Following Radical Prostatectomy

NCT00937768 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00937768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00937768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Temporary Androgen Deprivation Therapy in High Risk Prostate Cancer Following Radical Prostatectomy
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2009
Completion date
July 31, 2012
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, stage iia prostate cancer, stage iib prostate cancer, stage iii prostate cancer, stage iv prostate cancer